Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (Denmark) · Denmark

John Villumsen

John Villumsen publishes mostly in Endocrinology, Diabetes and Metabolism, Immunology and Epidemiology, on topics such as Psoriasis: Treatment and Pathogenesis, Diabetes Management and Research and Advancements in Transdermal Drug Delivery.

OpenAlex
World rank
#2,424,703
of 7,710,434 ranked researchers
Rank in Denmark
#18,234
of 43,819
Works
19
Citations
3.1k
Citations per work
162.3
h-index
14
i10-index 16Top 38% in Endocrinology, Diabetes and Metabolism
John Villumsen

What does John Villumsen research?

John Villumsen's work is mostly in Medicine (36%), Immunology and Microbiology (12%), Pharmacology, Toxicology and Pharmaceutics (8%).

Everything else: 7 works · 38.5% of their workHealth Sciences: 7 works · 36.5% of their workMedicine: 7 works · 36.5% of their workEndocrinology, Diabetes and Metabolism: 3 works · 17.3% of their workEpidemiology: 2 works · 9.6% of their workRheumatology: 2 works · 9.6% of their workLife Sciences: 5 works · 25.0% of their workImmunology and Microbiology: 2 works · 11.5% of their workImmunology: 2 works · 11.5% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 7.7% of their workPharmaceutical Science: 1 works · 7.7% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 5.8% of their workMolecular Biology: 1 works · 5.8% of their workTHEIR WORKJohn Villumsen19works
Life Sciences25%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else738.5%
    1. Medicine736.5%
    1. Immunology and Microbiology211.5%
    2. Pharmacology, Toxicology and Pharmaceutics17.7%
    3. Biochemistry, Genetics and Molecular Biology15.8%
  1. 1Endocrinology, Diabetes and Metabolism17% of their works
  2. 2Immunology12% of their works
  3. 3Epidemiology10% of their works
  4. 4Rheumatology10% of their works
  5. 5Pharmaceutical Science8% of their works
  6. 6Molecular Biology6% of their works

Research topics

Which keywords describe John Villumsen's research?

The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Type 1 Diabetes, IL-17, TH17 Cells, Diabetes, Hypoglycemia and Ankylosing Spondylitis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Glycemic Control82 topics
  2. Insulin Therapy82 topics
  3. Type 1 Diabetes72 topics
  4. IL-1761 topic
  5. TH17 Cells61 topic
  6. Diabetes51 topic
  7. Hypoglycemia51 topic
  8. Ankylosing Spondylitis41 topic
  9. Epidemiology42 topics
  10. Microneedles41 topic
  11. Solid Lipid Nanoparticles41 topic
  12. Spondyloarthritis41 topic
  13. Cardiovascular Outcomes31 topic
  14. Type 2 Diabetes31 topic
  15. Autoimmunity21 topic
  16. Dermatophytes21 topic
  17. Genetics21 topic
  18. Onychomycosis21 topic
  19. Phosphoethanolamine21 topic
  20. Synthetic21 topic

Where does John Villumsen work?

John Villumsen's main affiliation in the publication record is Leo Pharma (Denmark), Denmark.

How many publications and citations does John Villumsen have?

OpenAlex counts 19 works and 3,084 citations for John Villumsen, an h-index of 14, ranking #2,424,703 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John Villumsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.